Explore state-of-the-art clinical filling in Chicago
Parenteral drug development is complex, costly, and subject to many levels of risk during the clinical phases. Only a few drug products ever make it to phase III, through approval, and on into commercial manufacturing. Given the numerous hurdles that exist, realizing the drug development process efficiently during all phases has become ever more important. And, having the right partner on board to support the project is critical in preparing a valuable drug package that can be used for either further product development and commercialization, or for a successful out-licensing deal.
Explore state-of-the-art clinical filling in Chicago
Parenteral drug development is complex, costly, and subject to many levels of risk during the clinical phases. Only a few drug products ever make it to phase III, through approval, and on into commercial manufacturing. Given the numerous hurdles that exist, realizing the drug development process efficiently during all phases has become ever more important. And, having the right partner on board to support the project is critical in preparing a valuable drug package that can be used for either further product development and commercialization, or for a successful out-licensing deal.
The podcast will showcase Vetter´s service portfolio as a company in general, and its offering in the development service area in detail. In addition, this podcast will focus on the companies` capabilities in its Chicago development service site, including its customer base. An informative case study highlighting the critical expertise needed in today´s drug development environment will be presented.
Handling Sterile Potent, Powders Inside a Single Use, Disposable Aseptic Isolator with Martyn Ryder
April 28th 2021During this podcast we shall be discussing how sterile potent powders are becoming more common in the bio-pharmaceutical industry and the challenges around handling these powders in conventional aseptic containment systems. Review the overarching benefits of compliant. single use isolator systems when handling sterile products and how they mitigate the risk associated with potent product batch manufacture.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
